GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genenta Science SpA ADR GNTA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.99

+20.62%

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$7.0m

FY2019FY2025

Free cash flow

−$7.7m

FY2019FY2025

Shareholders' equity

$24.4m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross profit−$30,118−$51,930−$46,567−$6,695−$5,690−$1,974—
Research and development$2.9m$5.6m$7.1m$5.8m$3.9m$4.9m$4.1m
Operating income−$7.1m−$11.4m−$12.9m−$12.0m−$6.6m−$5.8m−$5.1m
Net income−$7.0m−$10.4m−$12.8m−$9.2m−$6.4m−$5.8m−$5.1m
Diluted earnings per share-0.30-0.57-0.70-0.51-0.35-0.40-0.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$35.6m$16.6m$25.0m$37.3m$44.7m$19.5m$23.8m
Cash and short-term investments$31.4m$14.1m$21.0m$33.3m$41.6m$17.3m$22.5m
Total liabilities$11.2m$2.6m$2.1m$2.6m$1.3m$2.6m$2.8m
Debt$8.5m$16,302$16————
Shareholders' equity$24.4m$14.0m$22.8m$34.8m$43.4m$16.9m$21.0m
Shares outstanding23m18m18m18m18m15m18m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−$7.7m−$7.0m−$12.5m−$8.3m−$7.8m−$6.7m−$2.8m
Capital spending−$8,514−$4,989−$15,399−$30,226−$10,059−$23,304−$23,304
Free cash flow−$7.7m−$7.0m−$12.5m−$8.3m−$7.8m−$6.8m−$2.8m

Latest quarters

By quarter end

Mar 2026Sept 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023Mar 2023
Gross profit−$15,671−$14,511−$26,135−$24,888−$23,389—−$23,389—
Operating income−$3.6m−$3.5m−$6.1m−$5.1m−$5.4m−$2,754−$7.5m−$7.7m
Net income−$3.0m−$4.0m−$5.7m−$4.5m−$5.4m−$2,728−$7.5m−$7.1m
Diluted earnings per share-0.14-0.17-0.31-0.25-0.29-0.00-0.41-0.39
Cash from operations−$1.0m−$6.0m————−$8.0m−$5.0m
Total assets$35.6m$24.1m$16.6m$21.2m$25.0m$25.0m$29.8m$37.3m
Cash and short-term investments$31.4m$19.7m$14.1m$18.9m$21.0m$21.0m$24.8m$33.3m
Debt——$14,962$14,541—$14,069—$13,663
Shareholders' equity$24.4m$13.5m$14.0m$18.8m$22.8m$22.8m$27.7m$34.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-16.2%4.0%—
Net income-8.8%3.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-5.0-4.1-3.8-5.8-16.6

Share price return

Finished calendar years

20252024202320222021
Return-46%3%-13%-48%0%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.